Israeli technology firm BioHarvest Sciences claims to have cracked the cell tissue production code as it brings the first fruits of its labor to market — a resveratrol-heavy offering made from cells taken from the skin of red grapes. Cannabinoids...
Swiss biotech firm Evolva has released their fourth and final installment on Resveratrol Supporting Healthy Aging in Women (RESHAW), with the last clinical study focusing on pain perception, menopausal symptoms and overall well-being.
Swiss biotech firm Evolva recently released their findings from the Resveratrol Supporting Healthy Aging in Women (RESHAW) clinical study, which examined cognition, cerebrovascular function and cardiometabolic markers in postmenopausal women.
From a resveratrol powder dispersible in cold liquid to a melt-in-your-mouth resveratrol pixie stick, Swiss ingredient supplier Evolva highlighted the flexibility of resveratrol fortification at the SupplySide East show in Secaucus, NJ last week.
Supplements of the polyphenol were found to increase blood flow in the brains of people with type 2 diabetes, a population known to be at increased risk of cognitive decline because of microvascular dysfunction.
Long term intake of a high-dose resveratrol supplement or drug may help people with mild to moderate Alzheimer's disease to stabilise a biomarker that declines when the disease progresses, say researchers.
Combining oil and extracts from grape seeds, two by-products from the wine industry, can form stable nanoemulsions for delivering resveratrol, and protect the ingredient for use in functional food applications.
Resveratrol, the powerful polyphenol found in red wine and certain fruits may work by activating an ‘evolutionarily ancient’ stress response in human cells, say researchers from The Scripps Research Institute.
A new study that concludes that high intakes of resveratrol may not reduce a person’s risk of cardiovascular disease or cancer has ‘very little to offer in the way of new or compelling information’, says the managing director of Biotivia.
A new study that concluded resveratrol does not have metabolic benefits in relatively healthy middle-aged women is "flawed" and "tells us very little about the benefits or non-benefits of resveratrol", says the chairman of GNC’s Medical...
A Danish government agency has committed €2.47m to a resveratrol study that will investigate multiple metabolic syndrome endpoints for the antioxidant including obesity, type-2 diabetes and osteoporosis.
As with many relatively new ingredients, resveratrol has had to prove its safety and efficacy to gain regulatory approval in various markets since its widespread commercial availability in the early 1990s.